GENEVA, May 5 -- KYON BIOTECH AG (Hardturmstr. 1038005 Zurich) filed a patent application (PCT/EP2024/080235) for "COMBINED ENZYMATIC-METABOLIC CANCER THERAPY" on Oct 25, 2024. With publication no. WO/2025/088121, the details related to the patent application was published on May 01, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): TEPIC, Slobodan (KaeferholzstraBe 348057 Zurich), CVETKOVIC, Goran (Oberer Gubel 158645 Jona), CVETKOVIC, Olivera (Oberer Gubel 158645 Jona)
Abstract:
The present invention relates to a treatment of cancer combining enzymatic with metabolic means of selective at...